Summary
Fludarabine monophosphate (FAMP), the 2-fluoro, 5′phosphate derivative of 9-β-D-arabinofuranosyl adenine (ara-A), is a purine nucleoside antimetabolite presently undergoing clinical testing for the treatment of a variety of malignancies including lymphoproliferative disorders and acute leukemia. We report a case of diffuse interstitial pneumonitis during treatment of chronic lymphocytic leukemia with FAMP. This resolved quickly with high dose steroids, recurred with steroid withdrawal, and abated with further steroid therapy. To our knowledge, this is the first reported case of fludarabine monophosphate associated pulmonary toxicity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cooper Jr JAD, White DA, Mathay RA: Drug induced pulmonary disease. Part 1: Cytotoxic Drugs. Am Rev Respir Dis 133:321–340, 1986
Grever MR, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley RL, VonHoff DD, Balcerzak SP: A SWOG study: Fludarabine monophosphate in chronic lymphocytic leukemia [Abstract]. Blood 66:200a, 1985 (suppl)
Hutton JJ, VonHoff DD, Kuhn J, Phillips J, Hersh M, Clark G: Phase I study of 9-β-D-Arabinofuranosyl-fluoroadenine 5′monophosphate (NSC 312 887), a new purine: Cancer Res 44:4183–4186, 1984
Warrell RP, Berman E: Phase I and II study of fludarabine phosphate in leukemia: Therapeutic efficacy with delayed central nervous system toxicity. J of Clin Oncol 4:74–79, 1986
Gale RP, Foon KA: Chronic lymphocytic leukemia, recent advances and treatment. Ann Intern Med 103:101–120, 1985
Chang AY, Kuebler JP, Pandya KJ, Israel RH, Marshall BC, Tormey DC: Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids. Cancer 57:2285–2290, 1986
Rubio FA: Possible pulmonary effects of alkylating agents [letter]. N Engl J Med 287:1150–1151, 1972
Rose MS: Busulphan toxicity syndrome caused by chlorambucil. Br Med J 2(5963):123, 1975
Cole SR, Myers TJ, Klatsky AU: Pulmonary disease with chlorambucil therapy. Cancer 41:455–459, 1978
Refvem O: Fatal intraalveolar and interstitial lung fibrosis in chlorambucil treated chronic lymphocytic leukemia. Mt Sinai J Med (NY) 44:847–851, 1977
Lane SD, Besa EC, Justh G, Joseph RR: Fatal interstitial lung disease following high dose chlorambucil therapy (Abstract). Proc Am Soc Clin Onc 20:313, 1979
Goddard P, Marty JP, Michel FB: Interstitial pneumonia and chlorambucil. Chest 76:471–473, 1979
Haupt HM, Hutchins GM, Moore GW: Ara-C lung: Non-cardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia. Am J Med 70:256–261, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hurst, P.G., Habib, M.P., Garewal, H. et al. Pulmonary toxicity associated with fludarabine monophosphate. Invest New Drugs 5, 207–210 (1987). https://doi.org/10.1007/BF00203548
Issue Date:
DOI: https://doi.org/10.1007/BF00203548